Autolus Therapeutics plc
AUTL
$1.35
-$0.16-10.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 64.23% | -79.05% | -27.92% | -32.35% | -186.34% |
| Total Depreciation and Amortization | 17.01% | 40.54% | 25.33% | -4.90% | 12.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -135.19% | -90.57% | 171.98% | 169.68% | 482.25% |
| Change in Net Operating Assets | -112.55% | 118.66% | -1,434.88% | -2.24% | 287.64% |
| Cash from Operations | -52.76% | -90.95% | -33.91% | 4.49% | -70.49% |
| Capital Expenditure | -652.34% | -540.12% | 80.84% | 85.28% | -133.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25,870.82% | -540.12% | 80.84% | 85.28% | -133.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.57% | 4,525.00% | -- | -- | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -906.39% | 1,717.80% | -100.00% |
| Cash from Financing | 130,365.22% | 4,525.00% | -849.32% | 81,350.51% | -99.99% |
| Foreign Exchange rate Adjustments | -491.04% | 505.57% | -80.39% | -116.18% | -11.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,502.23% | 5.02% | -48.03% | 1,417.59% | -107.53% |
